About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Neurodegenerative Diseases
›
top-articles
Neurodegenerative Diseases
2.2
(top 20%)
impact factor
892
(top 20%)
papers
29.3K
(top 10%)
citations
68
(top 10%)
h
-index
2.2
(top 20%)
extended IF
1.0K
all documents
31.8K
doc citations
130
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
Neurodegenerative Diseases
2013
6,857
2
Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood
Neurodegenerative Diseases
2008
414
3
Cognitive Impairment in Parkinson’s Disease: The Dual Syndrome Hypothesis
Neurodegenerative Diseases
2013
392
4
Amyloid-β Aggregation
Neurodegenerative Diseases
2007
290
5
Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer’s Disease
Neurodegenerative Diseases
2010
223
6
Hypermetabolism in ALS: Correlations with Clinical and Paraclinical Parameters
Neurodegenerative Diseases
2005
208
7
Alzheimer’s Disease in the Retina: Imaging Retinal Aβ Plaques for Early Diagnosis and Therapy Assessment
Neurodegenerative Diseases
2012
184
8
Celastrol Blocks Neuronal Cell Death and Extends Life in Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
Neurodegenerative Diseases
2005
175
9
Activation of the Unfolded Protein Response Is an Early Event in Alzheimer’s and Parkinson’s Disease
Neurodegenerative Diseases
2012
173
10
<i>Caenorhabditis elegans</i> MPP<sup>+</sup> Model of Parkinson’s Disease for High-Throughput Drug Screenings
Neurodegenerative Diseases
2004
167
11
Natalizumab: Targeting α<sub>4</sub>-Integrins in Multiple Sclerosis
Neurodegenerative Diseases
2008
147
12
The Vascular Hypothesis of Alzheimer’s Disease: Bench to Bedside and Beyond
Neurodegenerative Diseases
2010
142
13
Inhibition of Microglial Activation Protects Hippocampal Neurogenesis and Improves Cognitive Deficits in a Transgenic Mouse Model for Alzheimer’s Disease
Neurodegenerative Diseases
2012
141
14
Neuroinflammation and Blood-Brain Barrier Changes in Capillary Amyloid Angiopathy
Neurodegenerative Diseases
2012
140
15
Peripheral Inflammatory Cytokines as Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment
Neurodegenerative Diseases
2007
135
16
Soluble Beta-Amyloid Leads to Mitochondrial Defects in Amyloid Precursor Protein and Tau Transgenic Mice
Neurodegenerative Diseases
2008
134
17
Mitochondria in Amyotrophic Lateral Sclerosis: A Trigger and a Target
Neurodegenerative Diseases
2004
133
18
Assembly, Trafficking and Function of γ-Secretase
Neurodegenerative Diseases
2006
133
19
Excitotoxicity and Amyotrophic Lateral Sclerosis
Neurodegenerative Diseases
2005
132
20
Axonal Degeneration in Motor Neuron Disease
Neurodegenerative Diseases
2007
132
21
Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation
Neurodegenerative Diseases
2010
127
22
Neuropathological Aspects of Alzheimer Disease, Parkinson Disease and Frontotemporal Dementia
Neurodegenerative Diseases
2008
122
23
Amyloid-β-Derived Diffusible Ligands Cause Impaired Axonal Transport of Mitochondria in Neurons
Neurodegenerative Diseases
2010
120
24
Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study
Neurodegenerative Diseases
2018
119
25
Pathophysiology of Neuronal Energy Crisis in Alzheimer’s Disease
Neurodegenerative Diseases
2008
116
26
Significance of MRI in Diagnosis and Differential Diagnosis of Parkinson’s Disease
Neurodegenerative Diseases
2010
116
27
Progress in the Active Immunotherapeutic Approach to Alzheimer’s Disease: Clinical Investigations into AN1792-Associated Meningoencephalitis
Neurodegenerative Diseases
2008
113
28
Role of p53 in Neurodegenerative Diseases
Neurodegenerative Diseases
2012
109
29
Applications of Carbon Nanotubes in Neurobiology
Neurodegenerative Diseases
2007
107
30
Prevalence and Impact of Cerebrovascular Lesions in Alzheimer and Lewy Body Diseases
Neurodegenerative Diseases
2010
107
31
Clinical Criteria for the Diagnosis of Parkinson’s Disease
Neurodegenerative Diseases
2010
104
32
Lead Exposure as a Risk Factor for Amyotrophic Lateral Sclerosis
Neurodegenerative Diseases
2005
99
33
A Systematic Review and Meta-Analysis of CSF Neurofilament Protein Levels as Biomarkers in Dementia
Neurodegenerative Diseases
2007
97
34
Duodenal Levodopa Infusion Improves Quality of Life in Advanced Parkinson’s Disease
Neurodegenerative Diseases
2008
93
35
Default Mode Network and Extrastriate Visual Resting State Network in Patients with Parkinson’s Disease Dementia
Neurodegenerative Diseases
2012
93
36
Oophorectomy, Menopause, Estrogen, and Cognitive Aging: The Timing Hypothesis
Neurodegenerative Diseases
2010
91
37
TDP-43-Based Animal Models of Neurodegeneration: New Insights into ALS Pathology and Pathophysiology
Neurodegenerative Diseases
2011
91
38
It May Take Inflammation, Phosphorylation and Ubiquitination to ‘Tangle’ in Alzheimer’s Disease
Neurodegenerative Diseases
2006
90
39
Role of Immunity and Inflammation in the Pathophysiology of Neurodegenerative Diseases
Neurodegenerative Diseases
2015
89
40
Implications for the Kynurenine Pathway and Quinolinic Acid in Amyotrophic Lateral Sclerosis
Neurodegenerative Diseases
2005
88
41
<i>S</i>-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease
Neurodegenerative Diseases
2010
88
42
Prevention of Motor Neuron Degeneration by Novel Iron Chelators in SOD1<sup>G93A</sup> Transgenic Mice of Amyotrophic Lateral Sclerosis
Neurodegenerative Diseases
2011
88
43
Optimal Plasma Progranulin Cutoff Value for Predicting Null Progranulin Mutations in Neurodegenerative Diseases: A Multicenter Italian Study
Neurodegenerative Diseases
2012
88
44
Biomarkers for the Early Detection of Parkinson’s and Alzheimer’s Disease
Neurodegenerative Diseases
2008
87
45
Subsequent Risks of Parkinson Disease in Patients with Autoimmune and Related Disorders: A Nationwide Epidemiological Study from Sweden
Neurodegenerative Diseases
2012
86
46
Basic Research on Dopamine in Parkinson’s Disease and the Discovery of the Nigrostriatal Dopamine Pathway: The View of an Eyewitness
Neurodegenerative Diseases
2008
85
47
Plasma Urate and Progression of Mild Cognitive Impairment
Neurodegenerative Diseases
2009
85
48
Impaired Performance of Female APP/PS1 Mice in the Morris Water Maze Is Coupled with Increased Aβ Accumulation and Microglial Activation
Neurodegenerative Diseases
2013
85
49
MRI for Iron Mapping in Alzheimer's Disease
Neurodegenerative Diseases
2014
84
50
The Significance of α-Synuclein, Amyloid-β and Tau Pathologies in Parkinson's Disease Progression and Related Dementia
Neurodegenerative Diseases
2014
83
site/software ©
exaly
; All materials licenced under
CC by-SA
.